American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of patients with primary mediastinal B-cell lymphoma refractory or relapsed after frontline R-EPOCH chemotherapy
    Meeting Abstract

    Bakos, J.; Escribano Serrat, S.; Sawalha, Y.; Moskowitz, A.; Crawford, A.; Brooks, T. R.; Hill, B. T.; Falade, A. S.; Merryman, R. W.; Kamdar, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Demographic disparities in clinical trial enrollment of US patients with newly-diagnosed multiple myeloma
    Meeting Abstract

    Costa, B. A.; Debnath, N.; Costa, T. A.; Bertasi, R.; Mouhieddine, T. H.; Nath, K.; Rossi, A. C.
    Blood (2023)

    Fulltext@MSK | Save
  • AFM13 in combination with allogeneic natural killer cells (AB-101) in relapsed or refractory Hodgkin lymphoma and CD30+ peripheral T-cell lymphoma: A phase 2 study (LuminICE)
    Meeting Abstract

    Moskowitz, A.; Harstrick, A.; Emig, M.; Overesch, A.; Pinto, S.; Ravenstijn, P.; Schlüter, T.; Rubel, J.; Rebscher, H.; Graefe, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Mutant p53 drives the development of myelodysplastic syndromes via dysregulating pre-mRNA splicing in hematopoietic stem and progenitor cells
    Meeting Abstract

    Barajas, S.; Chen, S.; Vemula, S.; Yang, Y.; Simpson, E.; Cai, W.; Xiao, S.; Chen, H.; Halene, S.; Sukhanova, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A de novo supernumerary ring chromosome 1 causes B-cell acute lymphoblastic leukemia in monozygotic twins due to independent and partially convergent evolutionary trajectories
    Meeting Abstract

    Gutiérrez-Abril, J.; Gundem, G.; Fiala, E.; Liosis, K.; Farnoud, N.; Leongamornlert, D.; Amallraja, A.; Ossa, J. E. A.; Domenico, D.; Levine, M. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society
    Meeting Abstract

    Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; more...
    Blood (2023)

    Fulltext@MSK | Save